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Abstract – Genetic resistance to diseases is a multigenic trait governed mainly by the immune system
and its interactions with many physiologic and environmental factors. In the adaptive immunity,
T cell and B cell responses, the specific recognition of antigens and interactions between antigen pre-
senting cells, T cells and B cells are crucial. It occurs through a network of mediator proteins such as
the molecules of the major histocompatibility complex (MHC), T cell receptors, immunoglobulins
and secreted proteins such as the cytokines and antibodies. The diversity of these proteins that mainly
is due to an intrinsic polymorphism of the genes causes phenotypic variation in disease resistance.
The well-known linkage of MHC polymorphism and Marek’s disease resistance difference repre-
sents a classic model revealing immunological factors in resistance differences and diversity of medi-
ator molecules. The molecular bases in any resistance variation to infectious pathogens are vaguely
understood. This paper presents a review of the major immune mediators involved in resistance and
susceptibility to infectious diseases and their functional mechanisms in the chicken. The genetic in-
teraction of disease resistance with production traits and the environment is mentioned.
immunity / disease resistance / mhc / T cell receptor / immunoglobulin / cytokine
Résumé – Bases immunologiques des différences dans la résistance aux maladies chez le poulet.
La résistance génétique aux maladies est un trait multigénique qui est surtout gouverné par le système
immunitaire et ses interactions avec de nombreux facteurs physiologiques et environnementaux.
Dans l’immunité acquise, les réponses des cellules T et B, la reconnaissance spécifique des antigènes
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et les interactions entre les cellules présentant des antigènes, les cellules T et B, sont cruciales. Cela se
produit à travers un réseau de protéines médiatrices telles que les molécules du complexe majeur
d’histocompatibilité (CMH), les récepteurs des cellules T, les immunoglobulines et les protéines sé-
crétées telles que les cytokines et les anticorps. La diversité de ces protéines, qui est surtout due au po-
lymorphisme intrinsèque des gènes, entraîne une variation phénotypique dans la résistance aux
maladies. Le lien bien connu entre le polymorphisme du CMH et les différences dans la résistance à la
maladie de Marek représente un modèle classique révélant les facteurs immunologiques dans les dif-
férences de résistance et la diversité dans les molécules médiatrices. Les bases moléculaires impli-
quées dans toute variation de résistance aux pathogènes infectieux sont à peu près comprises. Cet
article présente une synthèse sur les principaux médiateurs de l’immunité impliqués dans la résis-
tance et la sensibilité aux maladies infectieuses chez le poulet et leurs mécanismes fonctionnels. L’in-
teraction génétique entre la résistance aux maladies et les traits de production et l’environnement est
mentionnée.
immunité / résistance aux maladies / complexe majeur d’histocompatibilité / récepteur de la
cellule T / immunoglobuline / cytokine
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1. INTRODUCTION
In any outbred population, genetically
determined difference in disease resistance
or susceptibility between individuals is
common. Some breeds or strains are inher-
ently resistant or less affected by a patho-
gen that can be fatal to other members of the
same species. Differences in disease resis-
tance between strains of chickens have long
been described [9, 59, 77]. Genetic resis-
tance to diseases is a great resource for the
control and prevention of diseases and to
the improvement of productivity in poultry [5,
17, 32]. The advantages of genetic resistance
havebeenemphasisedby theemergenceofviru-
lent and drug-resistant pathogens, restrictions on
the use of antimicrobials and the appearance
of certain diseases associated with selection
for production traits. In the past, the role of ge-
netic resistance in disease control in poultry
was limited because of the massive application
of chemotherapeutics.
Genetically determined diversity of the
immune system is the major cause for differ-
ences in resistance to diseases of infectious
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origin [41, 51]. A disease occurs if the im-
mune system fails to protect the body from
the injuries inflicted by the invading patho-
gen, due to insufficient-, misdirected- or
aberrant immune responses. The immune
response against infectious pathogens is an
elaborate process and varies among indi-
viduals. The immune competence of the
host could be evaluated using certain im-
mune parameters such as the antibody pro-
duction, lymphocyte proliferation, phago-
cyte activity, parasite load, etc. [4, 16, 53].
These immune parameters describe the im-
mune responsiveness that could be corre-
lated with resistance or susceptibility to a
pathogen. Yet, it is essential to discern the
molecular basis for variation in the immune
response and disease resistance.
The immune response operates through
interactions of the immune effector cells
(leukocytes) with the invading pathogen,
infected cells and cells that are committed
in scavenging and duly presenting antigens
to lymphocytes. The main immune effector
cell types are the T cells, B cells and the an-
tigen presenting cells (APC) [113]. The in-
teraction between these cells that takes
place by means of surface molecules, and
secreted proteins are crucial [36]. The main
mediators in the communication of the im-
mune cells are membrane proteins such as
molecules of the major histocompatibility
complex (MHC), T cell receptors (TcR)
and immunoglobulins (B cell receptors),
and secreted proteins such as cytokines and
antibodies [33, 51, 95]. These proteins are
immune intermediaries involved in antigen
binding and presentation, activating im-
mune effector cells and linking the different
events during the immune response. At the
molecular level, a difference in immune
competence could mainly be attributed to
the efficacy of the immune mediator mole-
cules and their diversity. These proteins are
genetically diverse and polymorphic. The
association between disease resistance or
susceptibility and polymorphism of these
proteins or their encoding genes has made
them potential immunogenetic markers for
resistance or susceptibility [35, 50]. Due to
the complexity of the immune system, the
actual functional mechanism of each im-
mune mediator protein and its marker sig-
nificance in disease resistance is obscure.
In the chicken, the association between
MHC polymorphism and resistance or sus-
ceptibility differences to infectious patho-
gens had long been recognised [13, 78]. In
most reports, the MHC is outlined in asso-
ciation to resistance or susceptibility to spe-
cific agents such as the Marek’s disease
virus (MDV). Yet, the role of the other im-
mune mediator proteins and their immuno-
genetics in disease resistance difference are
less described in chickens. This review
highlights the immune modulator proteins
with an outlook on innate differences in re-
sistance to infectious diseases. Their func-
tional mechanisms are discussed following
a brief outline of the immune system.
Finally, the interaction of disease resistance
with production traits and the environment
is addressed.
2. THE IMMUNE SYSTEM
AND ITS DIVERSITY
The innate immunity is the first line of
defence against invading pathogens. It in-
cludes inflammatory reaction, phago-
cytosis, acute phase reaction, complement
proteins, etc. that are constitutional non-
specific defence reactions (Tab. I) [113].
The other compartment of the immune sys-
tem, i.e., the adaptive immunity, is most
involved in individual differences in re-
sistance to infectious pathogens. The adap-
tive immune response mainly operate
through communications of the APC,
T cells and B cells by direct cell-to-cell con-
tact using MHC, TcR and
immunoglobulins and/or by secreted pro-
teins such as cytokines in a paracrine way
(Tab. I) [36, 51, 113]. The quantity and
quality of the immune response depends on
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the nature of the interaction of these mole-
cules. For instance, the association between
the MHC and TcR is decisive for T cell re-
sponses rather than a direct contact of the
T cell (TcR) with the pathogen or antigen.
Individual variation in immune response
is linked to the structural and functional di-
versity of the MHC, TcR, immunoglobu-
lins (antibodies), cytokines and certain
other proteins [1, 51]. These proteins are
encoded by multiple and polymorphic
genes [35, 50]. The polymorphism and ex-
pression differences of the genes are mainly
due to an intrinsic behaviour, but are also
generated and maintained by mutations.
The characteristic relation of the gene and
its protein products in disease resistance
has been mostly analysed in congenic and
transgenic animals. The expression of the
proteins could be analysed at protein level
(proteomics), or RNA (microarrays) or
DNA levels [25, 35]. Resistance marker
genes or quantitative trait loci (QTL) might
be identified through anonymous analysis
of the whole genome such as by
microsatellites. Yet, most of the known dis-
ease resistance QTL have been distin-
guished by using candidate gene approach
targeting certain immune mediator proteins
that are mentioned in the following sec-
tions.
3. THE MAJOR
HISTOCOMPATIBILITY
COMPLEX
3.1. Definition, MHC and disease
resistance
The major histocompatibility complex
(MHC), the B complex in the chicken, is
composed of heterodimeric transmem-
brane glycoproteins that are essential in the
presentation of antigens to T-lymphocytes
(reviewed in [72, 106]). The MHC mole-
cules (class I, class II and class IV or B-F,
B-L and B-G, respectively), belong to the
immunoglobulin superfamily with extra-
cellular regions composed of two N-ter-
minal antigen binding domains and two
constant domains that bind to the analogous
receptor molecules on the T cell membrane
[106]. Class I molecules are present in all cell
types. They are expressed with endogenously
synthesised peptides including self-derived
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Table I. Compartments of the immune system, functional cell types, mediator proteins and func-
tional characteristics of the system.
Compartments
of the immune
system
Cell types Mediator proteins Characteristics
Innate
immunity
Leukocytes,
natural killer
cells
Complement proteins,
acute phase proteins,
adhesion molecules,
radicals, oxides,
lysozymes, surfactants,
lectins
Target non-specific,
triggered by danger signals,
initiate adaptive response
Adaptive
immunity
Antigen
presenting cells,
B cells, T cells
Major histocompatibility
complex, T cell
receptors, B cell
receptors, antibodies,
cytokines
Target specific (qualitative
and quantitative), memory
function
and viral peptides. Class II MHC is ex-
pressed by antigen presenting cells (APC)
with processed exogenous antigens such as
bacterial antigens. The class I and II MHC
molecules are restriction molecules in APC
– T cell – B cell interactions [113]. T cells
identify antigenic peptides and are acti-
vated by recognising the MHC molecules
expressed with the antigen on the surface of
APC or infected cells [73].
The class IV MHC is so far exclusively
reported in avian species. It has originally
been established for expression on erythro-
cytes (reviewed in [68]) and later it was
recognised that many other cell types also
express the class IV MHC molecules,
such as liver cells, bursal and thymic
lymphoblast and stromal cells [118]. The
class IV MHC is involved in antibody re-
sponse, which is supposed to involve B cell
repertoire and the B cell antigen recogni-
tion and binding [65]. The other unique
MHC linked gene in the avian, is the Rfp-Y
that is recognised by DNA restriction frag-
ment pattern (Rfp) of the MHC class I, II
and IV genes in one MHC haplotype [14].
Besides the location of the gene being con-
tained within the MHC gene regions, its
function is not clear.
In the chicken, the MHC is closely asso-
ciated with resistance or susceptibility dif-
ferences to a number of diseases [80]. A
comprehensive review on the MHC linkage
with differences in disease resistance has
been given in several papers: resistance to
viral infections [18, 42, 66, 88, 104, 133,
137], resistance to bacterial infections [29,
46, 122], resistance to protozoal infection
[21, 86, 129], and autoimmune diseases
[114].
3.2. MHC diversity and its relevance
The MHC molecules are extremely di-
verse and are distinct between individual
[98]. The diversity of MHC at a population
level is due to the exceptional polymor-
phism of the genes encoding the class I, II
and IV molecules [87]. The uniqueness of
the MHC molecule in each individual
makes the immune response to vary be-
tween the MHC haplotypes. Because the T
cell response is restricted to MHC-bound
antigenic fragments, the diversity of the
MHC’s antigen-binding region has crucial
immunological consequences for the in-
duction of the adaptive immune responses
[79]. Thus, the multiplicity of MHC,
mainly at the antigen-binding region, is
crucial in order to cope with a range of anti-
genic peptides that could be encountered
[87]. The properties of the MHC haplotype,
regarding its affinity for a particular anti-
genic epitope, and the level of its expres-
sion have effect on T cell selection and
activation [116].
Chickens have relatively few MHC-
genes packed in a small region about 92-kb
long, which is only 5% of the correspond-
ing mammalian MHC (class I and II) gene
region [63]. Yet, the level of selection on in-
dividual alleles is higher in the chicken
compared to the mammals, that have many
highly expressed MHC class I and II genes.
There are over 28 MHC haplotypes in
chickens distinguished by serology [12].
Each haplotype expresses one dominant
class I MHC molecule with a different level
of expression [67]. MHC heterozygous in-
dividuals with two different alleles have ad-
vantages over homozygous; nevertheless,
in chickens, only two options for pep-
tide-binding specificity (MHC antigens)
are possible. The relatively simple and
compact nature of the chicken MHC-gene
that allows low level of recombination is
presumed somehow to contribute to the
MHC’s strict association with resistance
differences to certain infectious pathogens
(reviewed in [64, 67]). Its smallness might
create a window of variation, as life or
death, between the haplotypes. The close
correlation of MHC haplotypes with sus-
ceptibility differences to certain infections
such as the MDV might have been a conse-
quence of a parallel evolution of specific
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MHC haplotypes with important pathogens
that eventually let the survival of a few
haplotypes [64, 67].
Compared to the class I, II and IV gene
regions only limited Rfp-Y polymorphism
that contentiously correlated with differ-
ences in resistance to pathogens, especially
MDV, has so far been reported [76, 132].
Nevertheless, the Rfp-Y polymorphism and
its role in the MHC determined resistance
and susceptibility to infectious pathogens,
is a subject for further investigation.
3.3. Functional mechanisms
of the MHC in immune competence
Until this time, the exact effect of MHC
diversity on the differences in disease resis-
tance and susceptibility remained obscure,
besides the class I and II MHC molecules’
role in restriction of the T cell receptor. The
MHC-dependent resistance and suscepti-
bility in chickens is presumed to depend on
peptide-binding specificity of the domi-
nantly expressed class I molecule [64]. This
seems probable for resistance to smaller
pathogens or those viruses that contain few
peptides [66]. A good example is the MHC
determined resistance and susceptibility to
Rous sarcoma virus (RSV) wherein resis-
tance is related to the presence of appropri-
ate peptide binding class I MHC on the
surface of affected (tumour) cells to be re-
cognised by cytotoxic CD8+ T cells. The
RSV resistant strains, such as the CB line,
have MHC I molecules that effectively bind
to the peptide derived from the viral src
gene whereas in susceptible chicken, such
as the CC line, no efficient binding (and
presentation) of the peptide occurs [66,
120]. On the other hand, in MDV that is per-
haps the most explicit case regarding the
linkage of MHC and disease resistance or
susceptibility, the resistance differences be-
tween MHC haplotypes is related to the
level of class I molecule expression rather
than its specificity [67]. Chicken strains
carrying MHC haplotypes that express less
class I molecules, such as B21 strains, are re-
sistant to MDV, while those that abundantly
express class I molecules, such as the B19,
are most susceptible [42]. The mechanism
for the linkage between resistance and less
class I molecule expression is supposed to
be by a NK cell recognition and activation
at low MHC expression level. The role of
the class IV MHC molecules in antibody re-
sponse is speculated to be through enhanc-
ing the antigen recognition by B and T cells
and in the selection of B cells. Class IV anti-
gen is also presumed to play an adjuvant ef-
fect in antibody response against endogen-
ous or exogenous antigen [118]. Class IV
MHC haplotypes have divergent antibody
responses that in effect can be linked with
resistance differences to infectious patho-
gens attributed to difference in antibody
production (see below, Sect. 5) [65]. There
has been a conception that class IV mole-
cules might be involved in enteric mucosal
immunity against viruses, bacteria and
protozoal infection and have a role as re-
ceptors in intestinal epithelial barrier cells
where they are also expressed [97]. How-
ever, none of these functions of the class IV
is persuasive.
Further, the MHC has an extensive regu-
latory effect on many immune response
traits that elaborate its functional mecha-
nisms in resistance and susceptibility dif-
ferences. These include MHC involvement
in antibody responses [37, 69, 89], cytokine
production [43], activity of cytotoxic and
natural-killer (NK) cells [119]. For in-
stance, the MHC haplotype lines that are
resistant to MDV and RSV have enhanced
NK cell activity attributed to higher expres-
sion of the MHC-linked NK receptor-1
gene (NK-r1) [81]. The MHC haplotypes
also show a difference in T cell prolifera-
tion [127], serum complement proteins
[23], chemotactic activity of mononuclear
leukocytes [109] and macrophage effector
functions such as phagocytosis, bacterial
killing, respiratory burst and nitric oxide
synthesis [107]. Furthermore, the MHC
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gene is known to regulate the amount and
proportion of T cell sub-populations such
as the CD4+ and CD8+ T cells present in the
blood and peripheral tissues [39, 48]. The
incidence of other MHC related genes con-
tained within the MHC-gene region such as
the lectin gene, Tap2 (transporter associ-
ated with antigen processing) and NK-r1,
perhaps contribute in the classical MHC
haplotype linked differences in immune re-
sponses and disease resistance.
4. T CELL RECEPTORS
T cell receptors (TcR) are multichain
transmembrane heterodimers, consisting of
αand or γ and δ chains that are non-cova-
lently associated with an invariable CD3
molecule [24, 73]. The TcR is the antigen
recognising molecule of T cells that binds
with the MHC presented with the antigenic
peptide on the surface of APC or infected
cells. Consequently, the T cells are acti-
vated and differentiate into effector and/or
regulator cell types.
The MHC binding region of the TcR is
highly polymorphic and each circulating
T cell has a unique TcR [31, 73]. The pres-
ence of a range of T cells having different
TcR is vital to counter the numerous possi-
ble MHC-antigen complexes. The diversity
of TcR likely influences the immune re-
sponsiveness and disease resistance. There
are few studies in human [101] and sheep
[11] that indicate an association between
the polymorphism of TcR and a difference
in disease resistance. The diversity of TcR
is due to the presence of multiple TcR-
genes that are generated by a process called
gene rearrangement, that is a random re-
combination (shuffling) of the genes for the
variable (V), the diversity (D) (of chain)
and the joining (J) segment of the TcR-gene
[31]. By the V- (D)- J gene recombination,
numerous genes for the α, β, γ and TcR
chains are generated. Unfortunately, the
chickens have relatively few V, D and J
genes and this seems to limit TcR diversity
compared with mice in which more than
1015 αβTcR heterodimers are estimated
[128]. This lower TcR diversity in the
chicken might be an evolutionary conse-
quence of the presence of fewer MHC mol
ecules. Nevertheless, chickens are still capable
of making numerous TcR heterodimers [24].
The βTcR expressing T cells are the
main types of effector cells in the chicken
[24]. The different sub-populations of the
αβ T cells, such as those differentiated by
the V region of the chain, Vβ1+ (TCR2) or
Vβ2+ (TCR3) [75], or by the accessory re-
ceptor molecules CD4+ or CD8+ [92], have
distinct functional activities [3, 26]. The
amount and proportion of the T cell
sub-populations in blood and in peripheral
tissues have been correlated with differ-
ences in disease susceptibility [135, 139].
Quantitative and/or qualitative alterations
in T cells sub-population could influence im-
mune competence and resistance differences
against infectious pathogens and certain auto-
immune diseases such as scleroderma [135]
and thyroiditis [27]. In scleroderma, a fibrotic
disease, susceptible chickens have low
numbers of CD4+ T cells and defective T
cell activation that partly is attributed to a
defect in TcR mediated activation and/or
accessory in the CD28 (homologue) mole-
cules. In strains susceptible to autoimmune
thyroiditis, such as the OS strain, a selective
depletion of the Vβ1 T cells, mainly the
CD4+ cells, prevents the disease which in-
dicates a preferential involvement of the
TcR Vβ1 gene. A higher number of CD4+ T
cells or the percentage in comparison with
CD8+ T cells in blood, thymus or spleen has
immunomodulatory significance often
correlated with a wide-ranging immune
competence [38, 102]. In broiler chicken
lines that differ in the susceptibility to
malabsorption-syndrome associated to en-
teric infections, a difference in the amount
of resident CD4+ T cells and CD8+ T cells in
intestinal mucosa (villi) have been observed
(Zekarias and ter Huurne, unpublished results).
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There were more CD8+ T cells present in the
intestinal villi of broiler lines that are suscep-
tible to malabsorption- syndrome compared
to resistant lines. Similarly, a CD4+ cell dom-
inated mucosal T cell response has been re-
ported in chicken strains resistant to
coccidiosis, whereas the susceptible lines
have abundant CD8+ cells in the gut-associ-
ated lymphatic tissue [85, 139]. In contrast,
a CD8+ T cell biased response is predomi-
nant in chickens that are resistant to salmo-
nella infection and have higher response to
vaccination [10]. In white leghorns that are
resistant to Enterococcus faecalis-induced
amyloid arthropathy, a form of reactive
amyloidosis, we observed a higher number
of CD8+ T cells in the joints and in the pe-
ripheral blood than in the susceptible brown
layer breeds [140]. The association of resis-
tance and susceptibility with the amount or
proportion of CD4+ T cells and CD8+
T cells appear not coherent to a specific
type of infectious pathogens. The immune
competence correlated to a higher number
of CD4+ T cell might likely represent a re-
sistance against non-intracellular patho-
gens and antibody dominated response to
antigens whereas CD8+ T cells might have sig-
nificance in viral and intracellular infections
that mainly require a cell mediated response. In
turkeys, the presence of a higher number of
CD4+ (or helper) T cells than CD8+ (or
cytotoxic) T cells in the blood is associated
with higher susceptibility to infections with
Erysipelothrix rhusiopathiae, Pasteurella
multocida and Newcastle disease virus [8,
84]. Some studies in turkeys also correlate
the susceptibility differences to erysipelas,
pasteurella, and Newcastle infections with
polymorphism of the CD8 molecule [83].
Although not yet justified for its linkage
with resistance or susceptibility to any
pathogen, polymorphism of the CD8 mole-
cule is more common in the chicken than in
other species [93]. The significance of the
CD4+ and CD8+ TcR molecules in differ-
ences in immune competence and disease
resistance is perhaps related to their role in
restricting the reactivity of the TcR towards
either of the MHC classes (I or II) and
thereby determining the pattern of the im-
mune reaction towards either a helper cell
or cytotoxic cell dominated response.
5. IMMUNOGLOBULINS
Immunoglobulins are the major antigen
recognising proteins that can bind with free
antigenic peptides and are most essential in
the ultimate elimination of pathogens
[113]. Immunoglobulins are membrane re-
ceptor proteins on the B cell membrane or
secreted into circulation and mucosal sur-
faces by plasma cells as antibodies. The di-
versity and the amount (quantity) of
immunoglobulins are important factors in
resistance and susceptibility to infectious
pathogens [19]. The capability to produce
large amounts and varied types of antibod-
ies is often correlated with immune compe-
tence. For instance, the predisposition of
bursectomised young chicks to a wide
range of infectious agents seems largely an
attribute of a lack of adequate antibody pro-
duction or concentration [103].
There is a genetic difference in level of
antibody responses, which is mainly con-
trolled by the immunoglobulin-genes [19,
111]. Chicken strains have been categor-
ised as high antibody responders (HA) or
low antibody responders (LA) depending
on the amount of circulating antibodies
they produce against a given antigen [82,
121]. The most commonly used antigen for
selection for HA and HL lines is sheep red
blood cells [130]. The HA and LA lines
show differences in susceptibility or resis-
tance to pathogens. The HA chickens in
most cases appear better protected to exper-
imental infections with certain pathogens
such as the Newcastle disease virus,
Mycoplasma gallisepticum, Salmonella
enteritidis, and Escherichia coli, than the
LA lines [45, 136]. The HA and LA also
show difference in T cell responses; for
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instance, the HA lines have a high percent-
age of CD4+ T cells, while the LA lines
have more CD8+ T cells in the spleen and
thymus [102]. The LA chickens show an
enhanced cellular response characterised
by T cell proliferation and macrophage ac-
tivity that could improve their resistance to
intracellular bacteria and some viruses such
as MDV in which antibodies are of less im-
portance [43, 104]. The difference in the
other immune parameters such as macro-
phage activity [71] and in preferential T cell
responses and proliferation [43] and per-
haps the antibody response itself, might
possibly be related to the discrepancy in
cytokine responses in HA and LA lines. In
HA lines the Th2 cytokine responses are
supposed to be predominant and the Th1
cytokine responses likely characterise the
LA lines. This difference in cytokine re-
sponses (discussed in the following sec-
tion) could explain the difference in disease
resistance in conjunction with the differ-
ence in the humoral antibody response.
Several different antibodies each having
different specificity and affinity are pro-
duced during infection [19]. The diversifi-
cation of the antibodies produced during
infection is another factor in immune com-
petence. Antibody diversity is a result of the
multiplicity of the genes encoding for the
heavy (VH) and light (VL) immunoglobulin
chains that are generated by V –(D)– J gene
rearrangements in the progenitor B cells
(reviewed in [110, 112]). Several hundreds
of genes for the variable ‘V’ region of the
VH and VL are formed by the random re-
combination of the V – D (for VH) – J genes.
Chickens have relatively few functional VL
and VH genes; yet, they are capable of gen-
erating millions of different immunoglobu-
lin producing B cell repertoire [110]. In the
chicken, an additional diversification oc-
curs in the bursa by a process of gene con-
version [112]. In contrast to gene
rearrangement that is initiated early during
B cell ontogeny, diversification by gene
conversion is influenced by the bursal
microenvironment where the progenitor B
cells that colonised the bursa as of 10 days
embryonic age undergo proliferation and
differentiation into functional cells. Mal-
function in signalling the V-gene modifica-
tion and clonal selection for the functional
immunoglobulin genes in the bursa would
severely limit the diversification of anti-
bodies and B cell repertoires.
The process of V- (D)-J gene rearrange-
ment is controlled by a recombinase en-
zyme encoded by the recombination
activating genes (RAG1 and RAG2). In
mice, a genetic defect of RAG would cancel
immunoglobulin and TcR diversity as well
as the maturation of B cells and T cells
thereby diminishes disease resistance [99].
To our knowledge, there is hardly any spe-
cific disease to which resistance or suscep-
tibility is linked to B cell repertoire or
antibody diversity in the chicken. The ef-
fect of external antigens (pathogens) on im-
munoglobulin diversification is questionable.
Yet, there are indications that presence of
antigen or infection affects the eventual
B cell proliferation and repertoire and has
modest effect on B cell diversification
[112]. Chickens that are bursectomized at
early embryonic age of about 3 days have
profoundly reduced antibody diversity and
B cell repertoire [96]. In these chickens, the
level of antibody in the serum might remain
unaffected, but anticipated to be mono-
clonal. This might also attribute the suscep-
tibility of such chickens to many infectious
agents.
6. CYTOKINES
Cytokines are important molecules that
mediate and orchestrate the complex events
in the immune reaction, from the initiation
of the acute phase reaction to the clonal ex-
pansion of effector T and B cells [94]. They
are small glycoproteins (below 30 kDa)
produced by various cells, particularly
macrophages and CD4+ T cells are the main
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sources [61, 70]. In the mouse, two main
cytokine families, Th1 and Th2, are pro-
duced by the helper (CD4+) T cells [60, 94,
126]. These two cytokine categories essen-
tially determine the pattern of the immune
response. The Th1 cytokines include the in-
terferon-γ (IFN-γ ), interleukin-2 (IL-2) and
IL-12 that promote cell-mediated responses
by cytotoxic T cells and macrophage acti-
vation. On the other hand, the Th2 cyto-
kines such as IL-4, IL-5, IL-6 and IL-10
stimulate the humoral (antibody) response
[60]. The differentiation of a progenitor T
helper cell into the Th1 or Th2 helper cell
has a critical impact on the pattern of im-
mune response and subsequently on dis-
ease development [40, 54]. The initial
priming of the resting T helper cell (Th0)
occurs by the cytokines released instantly
by phagocytes (macrophages) during infec-
tion. The type of antigen, the type of APC,
the nature of cytokine gene expression and
the memory response all influence Th phe-
notype selection into Th1 or Th2 [47].
When IL-12 is dominant, Th0 will differen-
tiate into Th1 and in contrast, if IL-4 is in
abundance it promotes the differentiation
into the Th2 phenotype [60, 123].
A clear correlation between types of
cytokine response and differences in dis-
ease resistance has only been established in
mice especially with the prototypic differ-
ence in resistance to Leishmania major in-
fection [52]. The resistant mice strains have
a higher Th1 response characterised by
IL-12 and IFN-γ production, whereas the
susceptible strains are deficient in IL-12. In
chickens, the Th1/Th2 cytokine dichotomy
and difference in cytokine responses in cor-
relation with disease resistance or suscepti-
bility are still not well established. A
Th1-like response characterised by IFN-γ
production has been shown in chickens re-
sistant to MDV, Infectious Bronchitis,
Newcastle disease and salmonellosis [56,
61, 91]. There is a correlation between re-
sistance to these diseases and early and
higher IFN-γ production. A high level of
IFN-γ production has also been shown in
chicken strains that are resistant to
coccidiosis [20, 90, 139]. These observa-
tions suggest that chicken lines with an en-
hanced IFN-γ response are more resistant
to some viral and parasitic infections. Func-
tionally, IFN-γ is known to enhance macro-
phage activity and expression of MHC, to
increase the activity of cytotoxic T cells and
the secretion of the Th1 cytokines [62].
Lowenthal et al. [91] have shown that treat-
ment with recombinant IFN-γ enhances
resistance against coccidial infections and in-
creases vaccine response.
7. OTHER PROTEINS ASSOCIATED
WITH RESISTANCE
7.1. Natural resistance associated
macrophage protein 1 (Nramp-1)
Nramp-1 is a membrane phosphogly-
coprotein of macrophages that is involved
in resistance to intracellular bacterial infec-
tions [22, 131]. Originally, it was desig-
nated as Bcg/Lsh/Ity in mice for its
association with resistance to mycobacte-
rium, leishmania and salmonella infections
[124]. The actual immunological function
of Nramp-1 is not clear except for some in-
dications that it inhibits bacterial growth in
reticuloendothelial tissues in an early phase
of infection. The mechanism is supposed to
operate by modulation of the cytocidal ac-
tivity of macrophages by enhancing the
production of nitric oxide, phagolyso-
somal fusion, cytokine production and ex-
pression of class II MHC molecules [6, 46].
There is a link between Nramp-1 polymor-
phism and differences in mortality after sal-
monella infection in the chicken [57].
About eleven sequence variations within
the Nramp-1 gene have been identified that
are closely associated with the differences
in resistance to salmonellosis [58]. Amongst
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these, one sequence variant, an Arg. to Gln.
replacement at amino acid residue 223, was
more frequent in the susceptible chickens.
Other gene loci with a similar role as the
Nramp-1 gene are the Sal-1 [134], and Tnc
gene [58]. The functional identity of these
genes and their protein products need to be
further investigated.
7.2. Leukosis virus receptor proteins
There is a difference in the susceptibility
to Avian Leukosis virus (ALV) infection
that is correlated with the concentration of
certain virus receptor proteins on the cell
membrane [138]. ALV uses certain mem-
brane proteins as receptor sites to attach and
get access into the cell. The main receptor
proteins are those designated as Tva recep-
tors for ALV subtype A (ALV-A), CAR1
for subtypes B & D, and SEAR for sub-
type E [2, 15, 55]. These proteins are en-
coded by autosomal genes called tumour
virus (Tv) genes [7]. Chicken strains that
express many specific receptors on their
cell surface are susceptible to the corre-
sponding ALV subtype. By transgenics of
the Tv- gene, chicken lines resistant to
ALV-A have been produced, which is so far
a decent model in the application of
transgenics for disease resistance [55]. In
another mechanism, the receptor sites
could be saturated with endogenously syn-
thesised viral glycoproteins from endoge-
nous retroviral genes (ev-genes) [30]. Such
receptor interference by ev-genes could
prohibit the admission of exogenous vi-
ruses. Some ev-genes express viral envelope
glycoproteins like gp85, which block the re-
ceptor sites evoking resistance against exog-
enous infection with the ALV subtype that
needs the specific receptor [30]. Such recep-
tor saturation or blockage also limits the
congenital transmission of the virus [125].
For instance, the ev6-carrying chicken lines
express ALV-E envelope glycoproteins and
so are resistant to ALV subtype E infection
[125].
8. INTERACTIONS OF DISEASE
RESISTANCE, PRODUCTION
TRAITS AND THE ENVIRONMENT
Disease resistance is a phenotypic ex-
pression of immunogenetics that simulta-
neously is subjected to interactions with
several non-immune traits and the environ-
ment [44]. Production traits of commercial
importance are often reviled for negative
correlation with innate disease resistance
[105, 108]. For instance, the faster growth
rate in meat type chickens and turkeys has
adversely affected their immune compe-
tence against many infectious diseases [49,
100, 117]. This has raised a controversy on
the ongoing rigorous selection in poultry.
Unfortunately, strains with better genetic
resistance are in most cases poor producers;
for example, leukosis resistance and egg
yield. Perhaps an exception is the correla-
tion of MDV resistance and egg production
[74]. It seems that most production traits
develop at the expense of the energy that
would have been used for the immune phys-
iology.
The environment includes factors such
as husbandry, nutrition, hygiene and all
other management practices. The immune
responsiveness and disease resistance
would be affected positively or negatively
by the interactions with these external fac-
tors [34]. Genetic resistance could be di-
minished due to a sub-optimal immune
response because of an unreceptive envi-
ronment. Most of the time, selection for
specific production trait is carried in a con-
fined pathogen free environment that might
permit a maximum expression of the pro-
duction traits; yet, such environment biases
the genetics of the immune competence
and its actual interactions with the envi-
ronment. Besides, a pathogen free ‘opti-
mal environment’ condition is hardly
achievable under practical farming situa-
tions.
The genetics of resistance is strengthened
in a challenging environment, whereas a
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pathogen free condition diminishes the ex-
pression and development of genetic resis-
tance [115]. This appears to be the rationale
in Cole’s observation [28] that is after expos-
ing a parental flock to MDV, two lines
emerged at the fourth generation: one line
resistant and the other susceptible to experi-
mental infection with MDV. The resistant
line was less affected by the experimental
challenge; in contrast, the other line suffered
severe disease. The resistance of strains or
breeds that are originally from areas where a
disease is endemic is related to the immune
system’s adaptation to the challenge. In this
regard, crossbreeding of strains of divergent
origin could be a better compromise to
maintain and develop genetic resistance
from deteriorating due to selection under a
non-challenging environment.
9. CONCLUSION
Improving the genetics of disease resis-
tance is the most eligible approach for sus-
tainable control of infectious diseases in
poultry. The evolution of virulent infectious
pathogens and the limitations on the use of
chemotherapeutics, emphasise the advan-
tage of breeding for genetic resistance. In
order to develop the genetics of disease re-
sistance, it is eminent to recognise the im-
munological elements are liable for natural
resistance differences. A difference in dis-
ease resistance between individuals is the
result of genetic heterogeneity of the im-
mune response. The diversity of the MHC,
TcR, immunoglobulins and cytokines, con-
stitutes the major immunological bases in
resistance variations. The diversity of these
molecules is attributed mainly to the intrin-
sic polymorphism of their genes. The MHC
has been shown as a major immune factor
associated with resistance differences to
many infectious pathogens. Its broad effect
on the various immune response features
such as antibody responses, cytokine pro-
duction, and TcR expression would elabo-
rate its significance in disease resistance
differences. By using congenic or transgen-
ic chickens, the characteristic effect and the
mechanisms of the various immune media-
tor proteins might be better elucidated.
The identification of disease resistance
variation linked to immunologic traits and
genes/QTL would advance the developm-
ent of resistance markers and genetic engi-
neering for disease resistance. A marker-
assisted selection by introgression of the
resistance QTL is the most attractive ap-
proach to develop the genetic resistance.
The immune system counteracts each
pathogen with a distinct way. Therefore,
an optimal improvisation of the immune
competence by simultaneously consider-
ing different markers is essential to up-
grade the general resistance to a range of
pathogens. The immune mediators are also
the best targets for vaccine and therapeutic
interventions to enhance disease resistance.
Finally, the eminent effect of genetic inter-
actions of the immune physiology with cer-
tain non-immune related (production) traits
and the environment on disease resistance
needs to be taken into account in a global
strategy.
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